Larimar TherapeuticsLRMR
那斯達克 · USD
4.02
+0.08
(+2.03%)
收盤 12/12 04:59 (UTC+8)
12/12 04:59 (UTC+8)
Larimar TherapeuticsLRMR
4.02
+0.08
(+2.03%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 49,500 | 27,791 | 31,188 | 31,293 | 18,264 | 24,599 | 16,734 | 14,162 | 10,339 | 9,620 |
研發費用 | 44,932 | 23,367 | 26,552 | 26,738 | 13,919 | 19,682 | 12,939 | 10,648 | 6,585 | 5,875 |
推銷及管理費用 | 4,568 | 4,424 | 4,636 | 4,555 | 4,345 | 4,917 | 3,795 | 3,514 | 3,754 | 3,745 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -49,500 | -27,791 | -31,188 | -31,293 | -18,264 | -24,599 | -16,734 | -14,162 | -10,339 | -9,620 |
其他收入及費用 | 1,788 | 1,609 | 1,907 | 2,469 | 2,765 | 2,972 | 2,080 | 1,169 | 1,275 | 1,254 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -47,712 | -26,182 | -29,281 | -28,824 | -15,499 | -21,627 | -14,654 | -12,993 | -9,064 | -8,366 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -47,712 | -26,182 | -29,281 | -28,824 | -15,499 | -21,627 | -14,654 | -12,993 | -9,064 | -8,366 |
基本每股稅後盈餘(元) | -0.61 | -0.41 | -0.46 | -0.45 | -0.24 | -0.34 | -0.27 | - | -0.21 | -0.19 |
稀釋每股稅後盈餘(元) | -0.61 | -0.41 | -0.46 | -0.46 | -0.24 | -0.35 | -0.27 | -0.29 | -0.21 | -0.19 |
基本平均股數(千股) | 78324.00 | 64027.00 | 63964.00 | 63810.00 | 63806.00 | 63801.00 | 53553.00 | - | 43903.00 | 43897.00 |
稀釋平均股數(千股) | 78324.00 | 64027.00 | 63964.00 | 63810.00 | 63806.00 | 63801.00 | 53553.00 | - | 43903.00 | 43897.00 |
還原基本每股稅後盈餘(元) | -0.61 | -0.41 | -0.46 | -0.45 | -0.24 | -0.34 | -0.27 | - | -0.21 | -0.19 |
還原稀釋每股稅後盈餘(元) | -0.61 | -0.41 | -0.46 | -0.46 | -0.24 | -0.35 | -0.27 | -0.29 | -0.21 | -0.19 |
還原基本平均股數(千股) | 78,324 | 64,027 | 63,964 | 63,810 | 63,806 | 63,801 | 53,553 | - | 43,903 | 43,897 |
還原稀釋平均股數(千股) | 78,324 | 64,027 | 63,964 | 63,810 | 63,806 | 63,801 | 53,553 | - | 43,903 | 43,897 |
EBITDA(千元) | -47,949 | -26,556 | -29,948 | -29,929 | -17,138 | -23,318 | -15,157 | -13,545 | -9,553 | -8,319 |